Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Caux

Showing results (71-80 of 142) with videos related to

Pageof 15
Sort By:
Immunity|February 14, 2006
Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivoMarie Le Borgne, Nathalie Etchart, Anne Goubier, et al.
Journal of Clinical Medicine|November 6, 2019
Methotrexate Restores CD73 Expression on Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis Patients and May Contribute to Its Anti-Inflammatory Effect through Ado ProductionMarion Bossennec, Céline Rodriguez, Margaux Hubert, et al.
Clinical & Translational Immunology|July 19, 2021
Type 1 conventional dendritic cells and interferons are required for spontaneous CD4<sup>+</sup> and CD8<sup>+</sup> T-cell protective responses to breast cancerRaphaël Mattiuz, Carine Brousse, Marc Ambrosini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2014
TLR9 transcriptional regulation in response to double-stranded DNA virusesClaudia Zannetti, Peggy Parroche, Marine Panaye, et al.
Bulletin Du Cancer|January 8, 2019
[Some important breakthroughs in oncology and hematology in 2018: A selection by the editorial board of Bulletin du Cancer]Jacques-Olivier Bay, Thierry André, Christophe Caux, et al.
Molecular Pharmacology|January 16, 2003
Pharmacological analysis of calcium responses mediated by the human A3 adenosine receptor in monocyte-derived dendritic cells and recombinant cellsJames Fossetta, James Jackson, Gregory Deno, et al.
The Journal of Experimental Medicine|August 21, 2002
Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibodyAlain P Vicari, Claudia Chiodoni, Céline Vaure, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 21, 2025
High Expression of CCL2 Correlated With Dendritic Cell Recruitment in Neuroblastomas Associated With Opsoclonus-Myoclonus SyndromeMaureen Voirin, Alexia Gazeu, Benoit Dumont, et al.
Breast Cancer Research and Treatment|October 18, 2019
Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studiesDimitri Carene, Alicia Tran-Dien, Jérôme Lemonnier, et al.
Science Translational Medicine|October 25, 2019
Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockadeTala Shekarian, Eva Sivado, Anne-Catherine Jallas, et al.
Pageof 15

Showing results (71-80 of 142) with videos related to

Sort By:
Pageof 15
Immunity|February 14, 2006
Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivoMarie Le Borgne, Nathalie Etchart, Anne Goubier, et al.
Journal of Clinical Medicine|November 6, 2019
Methotrexate Restores CD73 Expression on Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis Patients and May Contribute to Its Anti-Inflammatory Effect through Ado ProductionMarion Bossennec, Céline Rodriguez, Margaux Hubert, et al.
Clinical & Translational Immunology|July 19, 2021
Type 1 conventional dendritic cells and interferons are required for spontaneous CD4<sup>+</sup> and CD8<sup>+</sup> T-cell protective responses to breast cancerRaphaël Mattiuz, Carine Brousse, Marc Ambrosini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2014
TLR9 transcriptional regulation in response to double-stranded DNA virusesClaudia Zannetti, Peggy Parroche, Marine Panaye, et al.
Bulletin Du Cancer|January 8, 2019
[Some important breakthroughs in oncology and hematology in 2018: A selection by the editorial board of Bulletin du Cancer]Jacques-Olivier Bay, Thierry André, Christophe Caux, et al.
Molecular Pharmacology|January 16, 2003
Pharmacological analysis of calcium responses mediated by the human A3 adenosine receptor in monocyte-derived dendritic cells and recombinant cellsJames Fossetta, James Jackson, Gregory Deno, et al.
The Journal of Experimental Medicine|August 21, 2002
Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibodyAlain P Vicari, Claudia Chiodoni, Céline Vaure, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 21, 2025
High Expression of CCL2 Correlated With Dendritic Cell Recruitment in Neuroblastomas Associated With Opsoclonus-Myoclonus SyndromeMaureen Voirin, Alexia Gazeu, Benoit Dumont, et al.
Breast Cancer Research and Treatment|October 18, 2019
Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studiesDimitri Carene, Alicia Tran-Dien, Jérôme Lemonnier, et al.
Science Translational Medicine|October 25, 2019
Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockadeTala Shekarian, Eva Sivado, Anne-Catherine Jallas, et al.
Pageof 15